KOCAA
TWST icon

Knights of Columbus Asset Advisors’s Twist Bioscience TWST Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,005
Closed -$730K – 425
2025
Q4 		$730K Sell
23,005
-117
-0.5% -$3.65K 0.04% 279
2025
Q3 		$651K Buy
23,122
+628
+3% +$19K 0.04% 282
2025
Q2 		$828K Sell
22,494
-684
-3% -$23.6K 0.05% 255
2025
Q1 		$910K Buy
23,178
+612
+3% +$27.6K 0.06% 238
2024
Q4 		$1.05M Buy
22,566
+57
+0.3% +$2.58K 0.07% 240
2024
Q3 		$1.02M Sell
22,509
-19,650
-47% -$935K 0.07% 240
2024
Q2 		$2.08M Buy
42,159
+592
+1% +$24.1K 0.14% 210
2024
Q1 		$1.43M Sell
41,567
-20,728
-33% -$748K 0.1% 230
2023
Q4 		$2.3M Buy
+62,295
New +$1.44M 0.15% 221

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Knights of Columbus Asset Advisors's TWST Position: Q1 2026 in Review

Knights of Columbus Asset Advisors sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 23,005 shares — an estimated $730K sold.

Knights of Columbus Asset Advisors first reported a position in TWST in Q4 2023 and held it in 9 quarters. The position peaked at $2.3M in Q4 2023. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Knights of Columbus Asset Advisors reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 23,005 Twist Bioscience shares in Q1 2026, an estimated $730K.
  • Knights of Columbus Asset Advisors first reported a position in Twist Bioscience in Q4 2023 and held it in 9 quarters.
  • Knights of Columbus Asset Advisors's Twist Bioscience position peaked at $2.3M in Q4 2023.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2026, filed 11 May 2026.